Skip to main content
TipRanks
Go Ultimate75% OFF

Hikma Pharmaceuticals (H5P) Q2 2023 Earnings Report

4 Followers

DE:H5P Q2 2023 EPS Results

Actual EPS
EUR 1.14
Consensus EPS
EUR 0.84
Beat/Miss
Beat by +EUR 0.29
One Year Ago EPS
EUR 0.81

DE:H5P Q2 2023 Revenue Results

Actual Revenue
EUR 1.39B
Expected Revenue
EUR 1.18B
Beat/Miss
Beat by +EUR 203.38M
YoY Revenue Growth
+23.66%

Earnings Announcement Details

Quarter
Q2 2023
Date
08/03/2023
Time
Before Open
Conference Call
Thursday, August 3, 2023
DE:H5P Upcoming Earnings

Hikma Pharmaceuticals's next earnings date is estimated for February 25, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:H5P Earnings History

DE:H5P earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 25, 20272026 (Q4)1.00-0.67――
Aug 06, 20262026 (Q2)0.981.121.083.28% (+0.04)
Feb 26, 20262025 (Q4)0.960.670.5619.06% (+0.11)
Aug 07, 20252025 (Q2)1.001.081.13-3.94% (-0.04)
Feb 26, 20252024 (Q4)―0.560.26118.22% (+0.30)
Aug 08, 20242024 (Q2)―1.131.14-0.70% (-0.01)
Feb 22, 20242023 (Q4)―0.261.06-75.87% (-0.81)
Aug 03, 20232023 (Q2)0.841.140.8139.48% (+0.32)
Feb 23, 20232022 (Q4)0.690.790.86-8.56% (-0.07)
Aug 04, 20222022 (Q2)0.860.810.85-4.58% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed